20 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
3336036	83	New potent antagonists of leukotrienes C4 and D4. 1. Synthesis and structure-activity relationships.	Ono Pharmaceutical
3027332	18	Substituted (aryloxy)alkanoic acids as antagonists of slow-reacting substance of anaphylaxis.	TBA
3016267	46	Synthesis and structure-activity relationship studies of a series of 5-aryl-4,6-dithianonanedioic acids and related compounds: a novel class of leukotriene antagonists.	TBA
9873435	10	Development of new chromanol antagonists of leukotriene D4.	Pfizer
26985325	62	Discovery of 3-Substituted 1H-Indole-2-carboxylic Acid Derivatives as a Novel Class of CysLT1 Selective Antagonists.	Shanghai Institute of Materia Medica
26200813	90	Discovery of Gemilukast (ONO-6950), a Dual CysLT1 and CysLT2 Antagonist As a Therapeutic Agent for Asthma.	Setsunan University
25800431	30	Discovery of a potent, orally available dual CysLT1 and CysLT2 antagonist with dicarboxylic acid.	Ono Pharmaceutical
25408836	44	Discovery of Highly Potent Dual CysLT1 and CysLT2 Antagonist.	Ono Pharmaceutical
3033245	28	Leukotriene receptor antagonists. 2. The [[(tetrazol-5-ylaryl)oxy]methyl]acetophenone derivatives.	TBA
1331447	32	Development of a novel series of styrylquinoline compounds as high-affinity leukotriene D4 receptor antagonists: synthetic and structure-activity studies leading to the discovery of (+-)-3-[[[3-[2-(7-chloro-2-quinolinyl)-(E)-ethenyl]phenyl][[3- (dimethylamino)-3-oxopropyl]thio]methyl]thio]propionic	Merck Frosst Centre For Therapeutic Research
9871597	65	A series of non-quinoline cysLT1 receptor antagonists: SAR study on pyridyl analogs of Singulair.	Merck Frosst Center For Therapeutic Research
9871521	32	Synthesis and SAR of a novel, potent and structurally simple LTD4 antagonist of the quinoline class.	Novartis Pharma
30613325	88	Discovery of Orally Bioavailable and Liver-Targeted Hypoxia-Inducible Factor Prolyl Hydroxylase (HIF-PHD) Inhibitors for the Treatment of Anemia.	Merck
23455026	2	Structure-based drug design using GPCR homology modeling: toward the discovery of novel selective CysLT2 antagonists.	Zhejiang University
9089329	48	Synthesis and structure-activity relationships of carboxylated chalcones: a novel series of CysLT1 (LTD4) receptor antagonists.	Vrije Universiteit
2547071	27	3,4-Dihydro-2H-1-benzopyran-2-carboxylic acids and related compounds as leukotriene antagonists.	Roche Research Center
2342072	46	Evolution of a series of peptidoleukotriene antagonists: synthesis and structure/activity relationships of 1,3,5-substituted indoles and indazoles.	Ici Pharmaceuticals Group
2170649	37	The development of a novel series of (quinolin-2-ylmethoxy)phenyl-containing compounds as high-affinity leukotriene receptor antagonists. 3. Structural variation of the acidic side chain to give antagonists of enhanced potency.	Rorer Central Research
2157009	49	Development of a novel series of (2-quinolinylmethoxy)phenyl-containing compounds as high-affinity leukotriene receptor antagonists. 1. Initial structure-activity relationships.	Rorer Central Research